BUPRENORPHINE WAIVER TRAINING FOR CLINICIANS

Pre-conference Session

  • Date:
  • Time: 8:00am - 5:00pm
  • Track: Clinical Practice
  • CME/CE: 8.0

Additional Fee Session
Sponsored by the Alcohol, Tobacco, and Other Drug Use (ATOD) Among Older Adults Special Interest Group

Moderator: Tiffany Y. Lu, MD, MS
Opioid use disorder increasingly affects older adults, yet treatment for opioid use disorder remains poorly integrated into settings where geriatric patients routinely receive care. Buprenorphine is one of three medications approved by the FDA to treat opioid use disorder, is highly effective, safe in older adults, and can be prescribed by primary care clinicians. Yet a paucity of primary care clinicians and geriatricians are waivered to prescribe buprenorphine. By completing this 8-hour training and passing the exam with 75% or greater, participants will become eligible to apply for the waiver to prescribe buprenorphine in the United States under the Drug Addiction Treatment Act of 2000 (DATA 2000). This training will also have a special focus on buprenorphine prescribing for older adults. The training is open to physicians, nurse practitioners (NP), and physician assistants (PA) however NP/PA need to complete more hours of training beyond this course (24 hours total) per the 2016 Comprehensive Addiction and Recovery Act (CARA) requirements.  Learning Objectives: (1) list factors important to patient selection for office-based buprenorphine treatment; (2) identify the clinically relevant pharmacological characteristics of buprenorphine, methadone, and naltrexone; and (3) describe the resources needed to establish office-based treatment with buprenorphine and other medications for patients with opioid use disorders.

Opioid Use Disorder and Treatment with Buprenorphine/Naloxone
Justina L. Groeger, MD, MPH
Patient Evaluation of the Older Adult for Opioid Use Disorder
Benjamin Han, MD, MPH
Clinical Uses of Buprenorphine for Older Adults
Michael Fingerhood, MD